Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Sensulin
company
About
Sensulin is a diabetes drug discovery company developing a once-a-day glucose-responsive insulin.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $230K
- Industries
- Biotechnology,Diabetes,Health Care
- Founded date
- Aug 9, 2011
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Sensulin, LLC is developing a true once-a-day glucose-responsive insulin, that may mimic a healthy human pancreas. Sensulin may eliminate the need for basal & prandial insulin, offer a substantial improvement in the standard of care, and most importantly, give those with diabetes a chance at a normal life.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$230K
Sensulin has raised a total of
$230K
in funding over 2 rounds. Their latest funding was raised on
Dec 11, 2013 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 11, 2013 | Grant | $230K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Sensulin is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
